abstract |
Disclosed are tricyclic compounds as bromodomains and extra terminal (BET) inhibitors represented by formula I, their synthesis and their use in treating disease. More specifically, for treating condensed heterocyclic derivatives useful as inhibitors of BET, methods of producing such compounds, and diseases and conditions in which inhibition of one or more BET bromodomains benefits. The method is disclosed. [Chemical 1] |